At Cancer Therapy China (managed by ZMKS international cancer therapy biotechnologies, Co, Ltd.), our mission is to provide cancer patients and their families with information about the most cutting-edge technology and the most promising cancer treatments available in the world. By using the most advanced labs and the revolutional technology, we always pair patients with the best hospitals in China for treatments with their particular situation.
Mr. Graham. who came toChina in early 2011 after of 3 years of chemo and radiotherapy treatment in Australia, now is returning for 2nd phase DC-CIK immunotherapy. And, with his thoughful idea, he wants to share his treatment experiences to all cancer patients and wish that his words and successful experience can be widely spread out. So, more of the cancer patients can seek for the proper treatment in China. And yet, he was told that there was nothing they could have done about his cancer in Australia back in few years ago.
DC-CIK cell therapy was successfully reduce lymphoma tumor of australian patient
Mr. Graham. 65 years old, came toChina after of 3 years of treatment in Australia, the doctor said they could not do anything more for him. He was diagnosed with lymphoma, in middle of chest, which is is too deep.for surgery, not suitable for radiation therapy and his bone marrow and immune system was too weak for intense Chemotherapy. However he was very lucky to hear about cancertherapychina from his friends, he was hoping that a different kind of treatment can help him improve his condition. After the doctors examine his reports, he went on and start a combination treatment with immunotherapy and cell therapy. After first course of treatment, there is a reduce in side of tumor on the sides and the tumors in the middle of the chest also gone down. He was happy with the result and he will continue with the two more treatments after he comes back from australia. He found that the staff was fantastic and the doctor was very friendly and very helpful at all time. Lets look forward for his next treatment in the future.
PET scan shows tumor size before and after treatment: 2.1cm VS. 1.5cm
In Aug 2007, 43 year old, Ms. Rosanna Wong was found with vaginal bleeding and leucorrhea, and was diagnosed with cervical cancer, and received a removal operation immediately. Two years later, she started with abdominal pain, edema, poor appetite, insomnia symptoms, and received chemotherapy and radiation at a local hospital which was ineffective. After a PET-CT, it was found that cervical cancer has already being metastasized with hydronephrosis, and doctor recommended withdrawal of the treatment.
In Nov 2009, Ms. Wong accepted 2 cycles of DC-CIK biotherapy treatment, metastases disappeared and hydronephrosis had gone. She gained back her appetites, with quality sleep, without any more of abdominal pain and edema. And she was discharged from hospital.
In the early 2011, 64 year old, Mr. Yang who lives in Beijing had a sarcoma surgery on his back. The result was very good. However, in 3months later, he was found with pulmonary metastases, subsequently he had chemotherapy to stop the tumor growing, indeed the size of tumor had decreased. Two months later, after the chemo, his back tumors were found with sign of growing. Repeatedly, he was treated with chemo, and his body has gradually become weaker and had a substantial weight lost, with side effect of hair lost.
Patients undergoing with minimally invasive treatment of argon-helium knife
In 2001, Ms. Zhang went to hospital for a check-up with chest pains, and she was diagnosed with advanced breast cancer, made radical resection of breast surgery, during the rehabilitation period, she had also received 3 courses of chemotherapy. 8 years later, due to continuous coughing, Ms. Zhang was found with lung tumors, further detailed diagnosed with pulmonary metastasis of breast cancer. Radiotherapy was not working, and chemotherapy resistance reaction occurs with serious side effects, such as oral ulcers, physical pain, insomnia, also accompanied by cough, chest pain.
Mr. Wu was diagnosised at a local clinic with cholangiocellular carcinoma postoperative, hepatitis b virus, hepatitis cirrhosis, splenomegaly.
On July 29th 2009, he has a liver resection under general anesthesia in a hospital in Wuhan + microwave-coagulation. Leaves after right hepatic low differentiation of cholangiocellular carcinoma with Portal vein of liver cirrhosis.
On Sept 3rd, 2009, chemotherapy after surgery in the hospital; same year, September 24th, interventional treatment for hepatocellular carcinoma.Since then, respectively on Nov, 2009, May and July 2010. Received 6 courses of CIK cells treatment, total of 18 transfusions at The People's Liberation Army 309 hospital. The treatment went as expected, no adverse reactions, highly improved the patient’s quality of life.Transfusion tests and comparison of image shows: tumor marker levels decreased significantly, not shown with signs of recurrence and metastasis after 10 months of CIK treatment. Thus, CIK cells therapy shows good prevention of recurrence and metastasis of cancer cells, and improved patient’s immunity, and improved the quality of life.
Mr. Fu, 53 years old from Yantai, Shandong, in year 2002 he was diagnosed with "left renal cell carcinoma", he has received operation of left kidney removal. In March 2008, he was found with lung metastases, during intermittent period used immunosuppressive therapy, but ineffective.
In Aug 2008, Mr. Fu came to the People's Liberation Army 309 Hospital tumor treatment center, with left kidney in renal cell carcinoma after excision of 6 years ago, found with lung metastasis for 5 months. After admission, tumor treatment center provided cell transfusion therapy of 2 courses, with remarkable improvement, stability of pulmonary lesions, and there was no sign of metastasis, and Mr. Yu was discharged on Sept 22.
In Feb 2009, at the follow-up with Mr. Fu, we found that he had taken with traditional Chinese medicine and thymus peptide to enhance his immunity system, with optimistic condition. In April, at another follow-up, he was in a stable condition. And, 6 months later, Mr. Fu came to the International Centre again for the second phase of cell therapy treatment. His quality of life was highly improved with stable condition after the treatment.
Mr. Chaker, a 37 years old Liver cancer patient from Tunisia. He was first diagnosed with heptatocellular carcinoma secondary, a cancer of liver; with chronic hepatits B infection back in 2008. Tumors with size of75mm and 55mm were found in his left liver. A year after surgical removal of the tumors, the doctors found the tumor cells have spread to other part of the liver and his lung. This was while he decided to come to cancertherapychina for his treatment. After the doctors in Beijing carefully examine his condition. He was treated with one session of chemotherapy, cancer target treatment and 12 rounds of DC-CIK immunotherapy. His AFP level has dropped from 35619.4ng/ml to 19373.5ng/ml.
"The treatment I received in cancertherapychina is Different and Better comparing to my previous treatments." In other countries, Mr. Chaker received the standard chemotherapy treatment like most places. In cancertherapychina, he received a combination of treatments: chemotherapy with DC-CIK immunotherapy, and gene therapy. On top of that, there are also other treatments such as cryoablation and traditional chinese herbal therapy and more that are available for him. Although not every treatment is suitable for his condition. He felt like in here, there are wide range of treatment options available depended on a cancer patient's needs which really opens up the possibilities for cancer treatment.
Victor from Russia, has been through a lot of difficulties the past few years ever since he was diagnosed with prostate cancer in a local hospital in Russia at September 2008. He decided to travel to a more promising hospital in Germany to treat his cancer. The surgery went well and the recovery was smooth. However, the good news was only temporary. In September 2009, a hospital in germany found out he has tumor on his right ureter. Along with right kidney, adrenal glands and bladder. In November 2009 at the Donetsk first hospital in Germany. His CT scan and cystoscopy has show the tumor inside right bladder was 1cm thick with symptoms of edema and inflammation response. The symptoms was serious.
Victor search online trying to find other treatments that could solve his problem. He came across a news that grab his attention. The news was the ZMKS international cancer therapy biotechnologies Co. using a new cancer treatment approach called CIK cell therapy to treat cancer patients. The result was good and Victor decide to come to China to solve his problem.
Nicholas 32 Years Old Was Diagnosed with Lymphatic Leukoencephalopathy
Nicholas, a 32 year old lawyer, husband, and father from Romania, was admitted to our centers on April 2, 2009. Nicholas and his wife Madalina have experienced tremendous ups and downs in their search for treatment for Nicholas’ cancer. He has Hodgkin’s disease (a lymphatic type of cancer) and was recently additional diagnosed with progressive multifocal leukoencephalopathy (PML).
Traveling from Romania, to Israel, and now to Beijing, the couple has searched the world for the best care, and they are now beginning to see very encouraging results from the therapy Nicholas is receiving at Cancer Therapy China. During their stay at the center, they have constantly been helped and supported by Nicholas' best friend Cezar. In the interview below with Madalina, she shares their experience after their third week of treatment at the centers.
O poveste romaneasca- Povestea dlui Nicolae Florescu
Internati in data de 2 aprilie 2009, Nicolae impreuna sotia sa Madalina, au avut parte de urcusuri si coborasuri ingrozitoare in cautarea unui tratament pentru forma de cancer a lui Niki, un tanar de 32 de ani, din Romania, care sufera de Maladia Hodgkin’s, o forma de cancer limfatic, care in ultimul timp, datorita sistemului imunitar deficitar a fost complicat si agravat cu leucoencefalopatie multifocala progresiva, facuta din cauza activarii virusului JC, asa cum a fost diagnosticat de medicii de la spitalul Rambam din Israel.
Calatorind atat in Israel, iar acum in China la Beijing, tanara familie a cautat prin lume cea mai buna terapie si rezolvare pentru problemele de sanatate ale lui Niki.
Dupa acceptarea si internarea in clinica - CTC (Cancer Therapy China)- cuplul a inceput sa vada rezultate foarte incurajatoare si imbucuratoare ale terapiilor medicale pe care Niki Florescu le-a facut. Pe toata perioada internarii ei au fost ajutati si sprijiniti de bunul prieten al lui Niki - Cezar. In interviul urmator, Madalina va impartasi experienta lor dupa cea de-a treia saptamana de cand se afla internati in clinica noastra.
Ms. D 55 years old from Netherlands received a combine treatment for her lung cancer
Ms. D, Diagnosed with lung adenocarinoma with chest pain, come to China for her treatment. After receiving a combime treatment of Chemotherapy, Antiangiogenesis therapy and Gene Therapy. Her lung lesion was greatly reduced with the disappearance of all symptoms. One tumor disappeared and the other tumor significantly decreased after 2 months of treatment.
Diagnosis: Small cell lung cancer. A lesion of size 5×3.5 cm was found in the central right lung (Fig. 1).
Treatment: In Aug. 2008, combination Chemotherapy with Cryoablation
Post-therapy status: Three months later, the success of the cryosurgery procedure was clearly confirmed, with the majority of tumor completely absent with no traces in remaining tissues (Fig. 2); five months later, the residual tumor necrosis tissues continued to shrink, and were resorbed down to a size of 1.5 cm across (Fig. 3); six months later, necrotic tissue was absorbed completely with only a little scar tissue left (Fig 4).
In the coming weeks, CTC researchers plan to publicly announce the cutting-edge progress they have made in the application of CIK therapy. In recent research, CIK cells cultured from umbilical cord blood were used in animal trials. In these trials, the new CIK cells effectively killed the cancer cells 80% of the time.
There is still more testing to be done, as animals are quite different than complex human bodies. However, umbilical cord CIK cells are showing great promise in the near future for human application. Dosage can greatly affect effectiveness, and researchers are currently testing variables regarding dosage, time, and interval of injection. Thus far, CTC researchers have successfully used CIK to kill 9 types of cancer: